Molly Gibson, PhD
Principal, Flagship Pioneering
Molly Gibson, PhD is a principal at Flagship Pioneering and works as part of a venture-creation team to find and grow companies at the intersection of biology and machine learning. Gibson currently serves as co-founder and chief innovation officer of Generate: Biomedicines. Prior to joining Flagship in 2017, she led computational biology at Kaleido Biosciences. In this role, she developed the company’s computational platform for the discovery of microbiome metabolic therapeutics, now in clinical development.